M. E. Hemler, Tetraspanin functions and associated microdomains, Nature Reviews Molecular Cell Biology, vol.264, issue.10, pp.801-812, 2005.
DOI : 10.1038/nm808

M. Rice and J. A. , McKeating: CD81 is required for hepatitis C virus glycoprotein-mediated viral infection, J Virol, vol.78, pp.1448-55, 2004.

J. Flint, J. Zhang, D. Yu, D. D. Butera, L. B. Ho et al., Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81- dependent manner, J Virol, vol.78, pp.8496-505, 2004.

T. Dubuisson and . Wakita, Cd81 Expression Is Important For Heterogeneous Hcv Permissiveness Of Huh7 Cell Clones, J Virol, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00183353

G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann, The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells, Journal of Virology, vol.81, issue.2, 2006.
DOI : 10.1128/JVI.01534-06

M. Cerretani, A. Pezzanera, A. Ceccacci, S. Vitelli, A. Levy et al., Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection, J. Virol, vol.74, pp.5933-5941, 2000.

P. Jones, C. M. Balfe, and J. A. Rice, McKeating: Diverse CD81 proteins support hepatitis C virus infection, J Virol, vol.80, pp.11331-11373, 2006.

P. Gardner and T. Dragic, CD81 is an entry coreceptor for hepatitis C virus, Proc Natl Acad Sci U S A, vol.101, pp.7270-7274, 2004.

M. Krieger, novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems, J Cell Biol J. Clin. Invest, vol.141, issue.56, pp.1539-50, 1998.

J. K. Patel, P. Ball, and . Borrow, Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets Perrimon: Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection, J Gen Virol Science, vol.86, issue.309, pp.2507-2519, 2005.

F. Malide, A. Basso, G. Remaley, T. L. Csako, A. P. Eggerman et al., CLA-1 and its splicing variant CLA- 2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells, Proc Natl Acad Sci, vol.103, pp.16888-93, 2006.

C. Bartosch, A. H. Bain, J. Patel, J. K. Dubuisson, and F. L. Ball, Cosset: Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus, Hepatology, vol.41, pp.265-74, 2005.

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.6023-6057, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

C. , N. Callens, E. Blanchard, A. Op-de-beeck, J. Dubuisson et al., Cosset: An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I, J Virol J Biol Chem, vol.79, issue.63, pp.8217-8246, 2005.

D. Malavasi, J. Larrey, J. M. Coste, A. Fabre, P. Sa-cunha et al., The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus, J Hepatol, vol.46, pp.411-420, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00374413

N. Beglova and S. C. Blacklow, The LDL receptor: how acid pulls the trigger, Trends in Biochemical Sciences, vol.30, issue.6, pp.309-326, 2005.
DOI : 10.1016/j.tibs.2005.03.007

R. Thomssen, S. Bonk, C. Propfe, K. Heermann, H. G. Koechel et al., Association of hepatitis C virus in human sera with beta-lipoprotein

V. Paranhos-baccala and . Lotteau, Characterization of low-and very-low-density hepatitis C virus RNAcontaining particles, J Virol, vol.76, pp.6919-6947, 2002.

J. T. Schmidt and . Stapleton, Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor, J. Virol, vol.74, pp.10055-62, 2000.

F. X. Heinz and S. L. , Flavivirus Structure and Membrane Fusion, Adv Virus Res, vol.59, pp.63-97, 2003.
DOI : 10.1016/S0065-3527(03)59003-0

A. E. Smith and A. Helenius, How Viruses Enter Animal Cells, Science, vol.304, issue.5668, pp.237-279, 2004.
DOI : 10.1126/science.1094823

S. Bressanelli, K. Stiasny, S. L. Allison, E. A. Stura, S. Duquerroy et al., Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation, The EMBO Journal, vol.23, issue.4, pp.728-766, 2004.
DOI : 10.1038/sj.emboj.7600064

J. Dubuisson, C. Wychowski, and Y. Rouille, Hepatitis C virus entry depends on clathrin-mediated endocytosis, J Virol, vol.80, pp.6964-72, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00105504

L. Meertens, C. Bertaux, and T. Dragic, Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, issue.23
DOI : 10.1128/JVI.01717-06

F. Baumert, M. P. Kieny, C. A. Pereira, and J. P. Martin, Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis, J Gen Virol, vol.87, issue.75, pp.2583-93, 2006.

B. B. Roccasecca, A. Ercole, A. Nicosia, and . Tramontano, A model for the hepatitis C virus envelope glycoprotein E2, Proteins, vol.40, pp.355-66, 2000.

F. X. Heinz, K. Stiasny, and S. L. Allison, The entry machinery of flaviviruses Dubuisson: Functional hepatitis C virus envelope glycoproteins, Arch Virol Voisset, C. and J. Biol Cell, vol.77, issue.96, pp.133-140, 2004.

D. Lavillette, B. Bartosch, D. Nourrisson, G. Verney, F. L. Cosset et al., Pecheur: Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes Rice: Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry Hepatitis C virus: an overview of current approaches and progress, J Biol Chem J Virol Drug Discov Today, vol.281, issue.4, pp.3909-3926, 1999.

P. Farci, H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan et al., Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization., Proceedings of the National Academy of Sciences, vol.91, issue.16, pp.7792-7798, 1994.
DOI : 10.1073/pnas.91.16.7792

R. H. Alter and . Purcell, Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

. Roggendorf, Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization, Arch Virol, vol.142, pp.523-557, 1997.

H. Fleming, R. W. Chapel, and . Chapman, Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up, Clin Exp Immunol, vol.110, pp.4-8, 1997.

. Chapman, Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C, Clin Immunol, vol.99, pp.320-324, 2001.

C. Logvinoff, M. E. Major, D. Oldach, S. Heyward, A. Talal et al., Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.101, issue.27, pp.10149-54, 2004.
DOI : 10.1073/pnas.0403519101

J. Purcell and . Bukh, Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proc Natl Acad Sci U S A, vol.102, pp.4560-4565, 2005.

K. G. Hadlock, R. Gish, J. Rowe, S. S. Rajyaguru, M. Newsom et al., Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2), Journal of Medical Virology, vol.125, issue.1, pp.23-32, 2001.
DOI : 10.1002/jmv.1096

D. M. Netski, T. Mosbruger, E. Depla, G. Maertens, S. C. Ray et al., Humoral Immune Response in Acute Hepatitis C Virus Infection, Clinical Infectious Diseases, vol.41, issue.5, pp.667-75, 2005.
DOI : 10.1086/432478

T. F. Roggendorf and . Baumert, Rapid induction of virusneutralizing antibodies and viral clearance in a singlesource outbreak of hepatitis C, Proc Natl Acad Sci U S A, vol.104, pp.6025-6055, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00395910

J. Dac, R. Dubuisson, D. Bartenschlager, and F. L. Lavillette, Cosset: High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI, J Biol Chem, vol.281, pp.18285-95, 2006.

H. Hahn, P. D. Kwong, and G. M. Shaw, Antibody neutralization and escape by HIV-1, Nature, vol.422, pp.307-319, 2003.

D. Robinson, L. Van-ryk, D. R. Wang, E. Burton, R. Freire et al., HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature, vol.420, pp.678-82, 2002.

A. Owsianka, A. W. Tarr, V. S. Juttla, D. Lavillette, B. Bartosch et al., Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.11095-104, 2005.
DOI : 10.1128/JVI.79.17.11095-11104.2005

H. Purcell, Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, vol.42, pp.1055-62, 2005.

Z. Y. Keck, A. Op-de-beeck, K. G. Hadlock, J. Xia, T. K. Li et al., Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions, Journal of Virology, vol.78, issue.17, pp.9224-9256, 2004.
DOI : 10.1128/JVI.78.17.9224-9232.2004

R. J. Mcclure, T. P. Brown, T. Hickling, R. Pietschmann, A. H. Bartenschlager et al., Ball: Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33, Hepatology, vol.43, pp.592-601, 2006.

R. C. Pannell, L. E. Sowder, and . Henderson, Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development, Antimicrob Agents Chemother, vol.41, pp.1521-1551, 1997.

M. R. Buckheit and . Boyd, Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin, Antimicrob Agents Chemother, vol.47, pp.2518-2543, 2003.

S. R. Shenoy, B. R. O-'keefe, A. J. Bolmstedt, L. K. Cartner, and M. R. Boyd, Selective interactions of the human immunodeficiency virus-inactivating protein 14 cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins, J Pharmacol Exp Ther, vol.297, pp.704-714, 2001.

C. Gustafson, J. Voisset, and . Dubuisson, Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans, J Biol Chem, vol.281, pp.25177-83, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00105507

J. Balzarini, Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses?, Antiviral Chemistry and Chemotherapy, vol.78, issue.1, pp.1-11, 2007.
DOI : 10.1126/science.291.5512.2370

. Lobigs, Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses

R. Lackman-smith, S. Ptak, and . Jiang, Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation

S. E. Vancompernolle, A. V. Wiznycia, J. R. Rush, M. Dhanasekaran, P. W. Baures et al., Small molecule inhibition of hepatitis C virus E2 binding to CD81, Virology, vol.314, issue.1, pp.371-80, 2003.
DOI : 10.1016/S0042-6822(03)00406-9

P. Patterson, Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogenactivated protein kinases, J Biol Chem, vol.280, pp.8031-8071, 2005.

L. Cai, M. C. De-beer, F. C. De-beer, and D. R. Van-der-westhuyzen, Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake, Journal of Biological Chemistry, vol.280, issue.4, pp.2954-61, 2005.
DOI : 10.1074/jbc.M411555200

C. Duverlie, J. Wychowski, and . Dubuisson, Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system
URL : https://hal.archives-ouvertes.fr/hal-00183312

E. Poveda, V. Briz, and V. Soriano, Enfuvirtide, the first fusion inhibitor to treat HIV infection Abbreviations: aa: amino acid; apo: apolipoprotein, AIDS Rev, vol.7, pp.139-186, 2005.